Clinical Trial Update: A Study of Brenipatide in Participants With Opioid Use Disorder [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating Brenipatide for opioid use disorder is currently recruiting. The study is sponsored by Eli Lilly and Company.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• Brenipatide

Snippet

Sponsor: Eli Lilly and Company | Conditions: Opioid Use Disorder | Phase 2 | Status: RECRUITING